These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors. Bielle F; Fréneaux P; Jeanne-Pasquier C; Maran-Gonzalez A; Rousseau A; Lamant L; Paris R; Pierron G; Nicolas AV; Sastre-Garau X; Delattre O; Bourdeaut F; Peuchmaur M Am J Surg Pathol; 2012 Aug; 36(8):1141-9. PubMed ID: 22790854 [TBL] [Abstract][Full Text] [Related]
11. Genetic predisposition in children with cancer - affected families' acceptance of Trio-WES. Brozou T; Taeubner J; Velleuer E; Dugas M; Wieczorek D; Borkhardt A; Kuhlen M Eur J Pediatr; 2018 Jan; 177(1):53-60. PubMed ID: 28929227 [TBL] [Abstract][Full Text] [Related]
12. Pediatric solid tumors and associated cancer predisposition syndromes: Workup, management, and surveillance. A summary from the APSA Cancer Committee. Grant CN; Rhee D; Tracy ET; Aldrink JH; Baertschiger RM; Lautz TB; Glick RD; Rodeberg DA; Ehrlich PF; Christison-Lagay E J Pediatr Surg; 2022 Mar; 57(3):430-442. PubMed ID: 34503817 [TBL] [Abstract][Full Text] [Related]
13. Arterial constriction after resection of neuroblastic tumors in children: Two-center retrospective study. Sosnowska-Sienkiewicz P; Januszkiewicz-Lewandowska D; Łosin M; Gowin E; Czauderna P; Mańkowski P J Pediatr Surg; 2021 Sep; 56(9):1661-1667. PubMed ID: 34092386 [TBL] [Abstract][Full Text] [Related]
14. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Bourdeaut F; Trochet D; Janoueix-Lerosey I; Ribeiro A; Deville A; Coz C; Michiels JF; Lyonnet S; Amiel J; Delattre O Cancer Lett; 2005 Oct; 228(1-2):51-8. PubMed ID: 15949893 [TBL] [Abstract][Full Text] [Related]
15. Performance of Tumor Surveillance for Children With Cancer Predisposition. Blake A; Perrino MR; Morin CE; Taylor L; McGee RB; Lewis S; Hines-Dowell S; Pandey A; Turner P; Kubal M; Su Y; Tang L; Howell L; Harrison LW; Abramson Z; Schechter A; Sabin ND; Nichols KE JAMA Oncol; 2024 Aug; 10(8):1060-1067. PubMed ID: 38900420 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors. Neubauer H; Li M; Müller VR; Pabst T; Beer M Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265 [No Abstract] [Full Text] [Related]
17. MYCN gene amplification in patients with neuroblastic tumors. Estiar MA; Fazilaty H; Aslanabadi S; Seifi M; Varghaei P; Rezamand A Cell Mol Biol (Noisy-le-grand); 2014 Sep; 60(3):23-8. PubMed ID: 25231001 [TBL] [Abstract][Full Text] [Related]
18. The McGill Interactive Pediatric OncoGenetic Guidelines: An approach to identifying pediatric oncology patients most likely to benefit from a genetic evaluation. Goudie C; Coltin H; Witkowski L; Mourad S; Malkin D; Foulkes WD Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097779 [TBL] [Abstract][Full Text] [Related]
19. Clinical practice of a genetics referral selection tool in pediatric cancer patients. Demirsoy U; Corapcioglu F Eur J Med Genet; 2021 Mar; 64(3):104167. PubMed ID: 33588069 [TBL] [Abstract][Full Text] [Related]
20. Evaluation and referral for child maltreatment in pediatric poisoning victims. Wood JN; Pecker LH; Russo ME; Henretig F; Christian CW Child Abuse Negl; 2012 Apr; 36(4):362-9. PubMed ID: 22571909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]